More about
Symptomatic, Inoperable Plexiform Neurofibromas
News
November 13, 2024
1 min read
Save
Koselugo significantly reduces neurofibromas in ongoing phase 3 study
An oral therapeutic significantly reduced the number of tumors in adults with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas, according to topline results from a phase 3 study.